...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

Positive news but can I play devils advocate for a moment.  There were a number of positive and very robust results that came out of the phase 2 trials that did not play out in BoM.  Is there not a similar risk of some of these big HR numbers from BOM meeting a similar fate in BoM2 or should those statistical CI percentages hold up?

Share
New Message
Please login to post a reply